Atox Bio to seek funds by year-end for more trials

TEL AVIV (Reuters) - Israeli biotechnology firm Atox Bio, developing a drug it hopes can treat severe infections such as those caused by flesh-eating bacteria and deadly viruses, expects to ask investors for more money this year to fund extended phase II trials.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/09/atox-bio-to-seek-funds-by-year-end-for_4.html